247 related articles for article (PubMed ID: 34504787)
1. Cystatin-B Negatively Regulates the Malignant Characteristics of Oral Squamous Cell Carcinoma Possibly
Xu TT; Zeng XW; Wang XH; Yang LX; Luo G; Yu T
Front Oncol; 2021; 11():707066. PubMed ID: 34504787
[TBL] [Abstract][Full Text] [Related]
2. Down-Regulation of Long Non-Coding RNA TINCR Induces Cell Dedifferentiation and Predicts Progression in Oral Squamous Cell Carcinoma.
Zhuang Z; Huang J; Wang W; Wang C; Yu P; Hu J; Liu H; Yin H; Hou J; Liu X
Front Oncol; 2020; 10():624752. PubMed ID: 33732637
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of key modules and hub genes associated with the pathological stage of oral squamous cell carcinoma by weighted gene co-expression network analysis.
Hu X; Sun G; Shi Z; Ni H; Jiang S
PeerJ; 2020; 8():e8505. PubMed ID: 32117620
[TBL] [Abstract][Full Text] [Related]
4. LDHA Promotes Oral Squamous Cell Carcinoma Progression Through Facilitating Glycolysis and Epithelial-Mesenchymal Transition.
Cai H; Li J; Zhang Y; Liao Y; Zhu Y; Wang C; Hou J
Front Oncol; 2019; 9():1446. PubMed ID: 31921691
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of IGF2BP2 Promotes Oral Squamous Cell Carcinoma Progression That Is Related to Cell Proliferation, Metastasis and Tumor-Infiltrating Immune Cells.
Zhou L; Li H; Cai H; Liu W; Pan E; Yu D; He S
Front Oncol; 2022; 12():809589. PubMed ID: 35299748
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor‑β/miR‑143‑3p/cystatin B axis is a therapeutic target in human ovarian cancer.
Guan W; Wang X; Lin Q; Zhang J; Ren W; Xu G
Int J Oncol; 2019 Jul; 55(1):267-276. PubMed ID: 31180557
[TBL] [Abstract][Full Text] [Related]
7. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
8. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.
Chang KP; Wang CL; Kao HK; Liang Y; Liu SC; Huang LL; Hseuh C; Hsieh YJ; Chien KY; Chang YS; Yu JS; Chi LM
Cancer; 2013 Nov; 119(22):4003-11. PubMed ID: 23963810
[TBL] [Abstract][Full Text] [Related]
10. Expression and epigenetic regulation of cystatin B in lung cancer and colorectal cancer.
Ma Y; Chen Y; Petersen I
Pathol Res Pract; 2017 Dec; 213(12):1568-1574. PubMed ID: 29037838
[TBL] [Abstract][Full Text] [Related]
11. MIEN1 promotes oral cancer progression and implicates poor overall survival.
Rajendiran S; Kpetemey M; Maji S; Gibbs LD; Dasgupta S; Mantsch R; Hare RJ; Vishwanatha JK
Cancer Biol Ther; 2015; 16(6):876-85. PubMed ID: 25996585
[TBL] [Abstract][Full Text] [Related]
12. LncRNA AC007271.3 promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wnt/β-catenin signaling pathway.
Shao TR; Zheng ZN; Chen YC; Wu QQ; Huang GZ; Li F; Zeng WS; Lv XZ
Life Sci; 2019 Dec; 239():117087. PubMed ID: 31759044
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Potential Prognostic Value of Peroxiredoxin 1 in Oral Squamous Cell Carcinoma.
Shen Y; Xu H; Li L; Lu Y; Zhang M; Huang X; Tang X
Cancer Manag Res; 2021; 13():5725-5737. PubMed ID: 34290530
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance and the Role of Guanylate-Binding Protein 5 in Oral Squamous Cell Carcinoma.
Liu PF; Shu CW; Lee CH; Sie HC; Liou HH; Cheng JT; Ger LP; Chen CL; Chen CC; Chen CF
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439200
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
[TBL] [Abstract][Full Text] [Related]
16. LncRNA HOTAIR promotes the invasion and metastasis of oral squamous cell carcinoma through metastasis-associated gene 2.
Tao D; Zhang Z; Liu X; Zhang Z; Fu Y; Zhang P; Yuan H; Liu L; Cheng J; Jiang H
Mol Carcinog; 2020 Apr; 59(4):353-364. PubMed ID: 31995261
[TBL] [Abstract][Full Text] [Related]
17. Cathepsin K associates with lymph node metastasis and poor prognosis in oral squamous cell carcinoma.
Leusink FK; Koudounarakis E; Frank MH; Koole R; van Diest PJ; Willems SM
BMC Cancer; 2018 Apr; 18(1):385. PubMed ID: 29618339
[TBL] [Abstract][Full Text] [Related]
18. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
Kang Y; Zhang Y; Sun Y
Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of RhoC Inhibits Oral Squamous Cell Carcinoma Cell Invasion and Metastasis via Regulation of HMGA2.
Gao F; Yin P; Wu Y; Wen J; Su Y; Zhang X
J Oncol; 2021; 2021():6644077. PubMed ID: 33519932
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of FOXD2-AS1 promotes cell proliferation and migration and predicts poor prognosis in oral squamous cell carcinoma: a study based on TCGA data.
Liu Z; Zhou W; Lin C; Wang X; Zhang X; Zhang Y; Yang R; Chen W; Cao W
Aging (Albany NY); 2020 Dec; 13(2):2379-2396. PubMed ID: 33318296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
